Register for an account


Enter your name and email address below.

Your email address is used to log in and will not be shared or sold. Read our privacy policy.


Website access code

Enter your access code into the form field below.

If you are a Zinio, Nook, Kindle, Apple, or Google Play subscriber, you can enter your website access code to gain subscriber access. Your website access code is located in the upper right corner of the Table of Contents page of your digital edition.


72. Protein Boost Halts Huntington's

Treatment offers hope to thousands afflicted by the neurodegenerative disease.

By Jill NeimarkJanuary 28, 2013 6:00 PM
Lawrence Berkeley National Laboratory


Sign up for our email newsletter for the latest science news

In July researchers investigating Huntington’s disease announced a treatment that can eliminate the distorted proteins that cause the illness, offering hope to the 30,000 people afflicted in the United States. Huntington’s disease causes neurons to waste away in certain parts of the brain, resulting in cognitive decline, involuntary movement, and eventually death. When mice with the disease were given increased amounts of the protein PGC-1-alpha, which is naturally present in both mice and humans, the neural decay was dramatically reduced.

According to the study’s lead researcher, geneticist Albert La Spada of the University of California, San Diego, "the prospect of an oral drug is conceivable." The PGC-1-alpha protein has also been shown to play a role in other neurodegenerative disorders like Parkinson's and possibly Alzheimer's.

Next, La Spada wants to research a drug that will activate the protein in mice. In three to five years, he estimates, human trials could begin.

3 Free Articles Left

Want it all? Get unlimited access when you subscribe.


Already a subscriber? Register or Log In

Want unlimited access?

Subscribe today and save 50%


Already a subscriber? Register or Log In